The strategic appointment is also critical to reinforcing Healthium’s market leadership, corporate governance and deep domain expertis
The appointment is effective from May 01, 2023 for five years
Franson will help biopharma clients design a phased approach to inform and execute clinical development plans
Venkat Nageswar Chalasani has been appointed as an Independent Director of Apitoria Pharma with effect from April 4, 2023
Abbas will closely partner with CBC's business teams to identify, assess, and pursue investment opportunities and strategic acquisitions
He is Proficient in overseeing and leading teams for running successful business operations
Dr. Hubbard brings more than 35 years of experience in the biopharmaceutical and pharma-tech services industries and CROs.
Julie is recognized as a highly engaging multi-cultural leader skilled in fluidly partnering with cross-functional teams to deliver results.
She was the CEO of Tata Insights and Quants a Division of the Tata Industries Ltd.
Subscribe To Our Newsletter & Stay Updated
